Skip to main content
. 2011 Oct 20;16(11):1508–1519. doi: 10.1634/theoncologist.2011-0115

Figure 2.

Figure 2.

Time to first onset of HFSR/HFS by the Kaplan–Meier method during the SOLTI-0701 trial [47]. (A): Any grade event. (B): Grade 3 events.

aSafety population (patients who received any study drug[s]).

Abbreviations: CAP, capecitabine; HFS, hand–foot syndrome; HFSR, hand–foot skin reaction; PL, placebo; SOR, sorafenib.